Innovating Works

OPTM.RX LTD

Desconocido
OPTM.RX: Novel drug for dry age related macular degeneration OPTM.RX LTD tramitó un HORIZON EUROPE: HORIZON-EIE-2022-SCALEUP-02 OphtiMedRx is an ophthalmic drug development start-up company led by a team of exceptional women physicians and scientists led by Dr. Dana R...
2023-06-05 - 2024-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.